Qiagen N.V. Stock price

Equities

QGEN

NL0012169213

Biotechnology & Medical Research

Market Closed - Nyse 04:00:02 2023-11-27 pm EST Intraday chart for Qiagen N.V. 5-day change 1st Jan Change
40.59 USD -0.73% +1.83% -18.61%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
Sales 2023 * 1,963 M Sales 2024 * 2,065 M Capitalization 9,262 M
Net income 2023 * 345 M Net income 2024 * 401 M EV / Sales 2023 *
5,07x
Net Debt 2023 * 685 M Net Debt 2024 * 197 M EV / Sales 2024 *
4,58x
P/E ratio 2023 *
27,0x
P/E ratio 2024 *
22,9x
Employees 6,000
Yield 2023 *
-
Yield 2024 *
-
Free-Float 98.49%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.73%
1 week+1.83%
Current month+8.44%
1 month+12.41%
3 months-9.21%
6 months-11.89%
Current year-18.61%
More quotes
1 week
40.57
Extreme 40.5697
41.23
1 month
34.74
Extreme 34.74
41.23
Current year
34.74
Extreme 34.74
51.18
1 year
34.74
Extreme 34.74
51.18
3 years
34.74
Extreme 34.74
59.00
5 years
25.04
Extreme 25.04
59.00
10 years
20.21
Extreme 20.2085
59.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 2015
Founder 68 1996
Director of Finance/CFO 55 1998
Members of the board TitleAgeSince
Director/Board Member 73 2011
Founder 68 1996
Director/Board Member 64 2021
More insiders
Date Price Change Volume
23-11-27 40.59 -0.73% 1,523,100
23-11-24 40.89 +0.59% 387,948
23-11-22 40.65 +0.74% 1,381,307
23-11-21 40.35 +1.23% 1,224,777

Delayed Quote Nyse, November 27, 2023 at 04:00 pm EST

More quotes
Qiagen N.V. is one of the world's leaders in designing, manufacturing, and marketing chemical products for the isolation, purification, and manipulation of DNA (deoxyribonucleic acid) and RNA (ribonucleic acid). In 2022, the group developed more than 500 core consumable products and automated solutions through its over 35 locations worldwide. Net sales are distributed geographically as follows: Europe/Middle East/Africa (34.2%), the United States (42.5%), America (4.1%) and other (19.2%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.59USD
Average target price
48.47USD
Spread / Average Target
+19.41%
Consensus
1st Jan change Capi. (M$)
-18.61% 9 262 M $
+66.85% 40 453 M $
+2.85% 38 458 M $
-56.73% 29 633 M $
-23.90% 29 066 M $
+38.69% 22 180 M $
-33.01% 19 978 M $
+1.43% 17 370 M $
-16.90% 10 860 M $
-24.88% 9 846 M $
Other Biotechnology & Medical Research
  1. Stock
  2. Equities
  3. Stock Qiagen N.V. - Nyse
-40% off Black Friday : Our subscriptions help you unlock the best investment opportunities.
Enjoy this offer